IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price TargetPosted by On




POTOMAC, Md.–(BUSINESS WIRE)– #AD–IGC Ascendiant Coverage



Source link

Business

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.